Biogen to acquire rare disease drugmaker Reata for $7.3B
5 highly anticipated FDA decisions for rare diseases coming this year
AstraZeneca buys Pfizer’s early gene therapy work for up to $1B
What's a fair price for a prescription drug? Medicare's about to weigh in
*please scroll down for all the latest news*
